loadpatents
name:-0.021433115005493
name:-0.013226985931396
name:-0.0036919116973877
Ohtomo; Toshihiko Patent Filings

Ohtomo; Toshihiko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ohtomo; Toshihiko.The latest application filed is for "dosage regimen for combination therapy using pd-1 axis binding antagonists and gpc3 targeting agent".

Company Profile
3.26.34
  • Ohtomo; Toshihiko - Tokyo JP
  • Ohtomo; Toshihiko - Ibaraki JP
  • Ohtomo; Toshihiko - Shizuoka N/A JP
  • Ohtomo; Toshihiko - Shizuoka-ken JP
  • Ohtomo; Toshihiko - Gotemba JP
  • Ohtomo; Toshihiko - Nishihari-mura Nishihari-gun JP
  • Ohtomo; Toshihiko - Gotemba-shi JP
  • Ohtomo; Toshihiko - Gotenba JP
  • Ohtomo, Toshihiko - Gotenba-shi JP
  • Ohtomo, Toshihiko - Gotenba-shi Shizuoka JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
GPC3-targeting therapeutic agent which is administered to patient for whom the GPC3-targeting therapeutic agent is effective
Grant 11,376,326 - Ohtomo , et al. July 5, 2
2022-07-05
GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy
Grant 10,782,300 - Ohtomo , et al. Sept
2020-09-22
Dosage Regimen For Combination Therapy Using Pd-1 Axis Binding Antagonists And Gpc3 Targeting Agent
App 20200216542 - OHTOMO; Toshihiko ;   et al.
2020-07-09
Method for assaying soluble GPC3 protein
Grant 10,451,627 - Ohtomo , et al. Oc
2019-10-22
Gpc3-targeting Therapeutic Agent Which Is Administered To Patient For Whom The Gpc3-targeting Therapeutic Agent Is Effective
App 20180169237 - OHTOMO; Toshihiko ;   et al.
2018-06-21
Cancer diagnosis and treatment of cancer using anti-ROBO1 antibody
Grant 9,644,029 - Aburatani , et al. May 9, 2
2017-05-09
GPC3-Targeting Drug Which Is Administered To Patient Responsive To GPC3-Targeting Drug Therapy
App 20170073426 - OHTOMO; Toshihiko ;   et al.
2017-03-16
Method For Assaying Soluble Gpc3 Protein
App 20170010270 - OHTOMO; Toshihiko ;   et al.
2017-01-12
Gene overexpressed in cancer
Grant 9,434,775 - Aburatani , et al. September 6, 2
2016-09-06
Gene overexpressed in cancer
Grant 9,376,475 - Aburatani , et al. June 28, 2
2016-06-28
Cancer Diagnosis and Treatment of Cancer Using Anti-Robo 1 Antibody
App 20150291694 - ABURATANI; Hiroyuki ;   et al.
2015-10-15
Gpc3-targeting Drug Which Is Administered To Patient Responsive To Gpc3-targeting Drug Therapy
App 20150285806 - Ohtomo; Toshihiko ;   et al.
2015-10-08
Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
Grant 8,940,488 - Aburatani , et al. January 27, 2
2015-01-27
Degraded TPO agonist antibody
Grant 8,586,039 - Tsuchiya , et al. November 19, 2
2013-11-19
Degraded Agonist Antibody
App 20130295096 - Fukushima; Naoshi ;   et al.
2013-11-07
Methods of screening compounds inhibiting signal transduction through inflammatory cytokines
Grant 8,105,799 - Tsuchiya , et al. January 31, 2
2012-01-31
Degraded Tpo Agonist Antibody
App 20120015436 - Tsuchiya; Masayuki ;   et al.
2012-01-19
Degraded TPO agonist antibody
Grant 8,034,903 - Tsuchiya , et al. October 11, 2
2011-10-11
Gene overexpressed in cancer
App 20110082284 - Aburatani; Hiroyuki ;   et al.
2011-04-07
Reshaped human anti-HM 1.24 antibody
Grant 7,892,543 - Ono , et al. February 22, 2
2011-02-22
Gene overexpressed in cancer
Grant 7,812,128 - Aburatani , et al. October 12, 2
2010-10-12
Expressing transporters on viral envelopes
Grant 7,666,610 - Saitoh , et al. February 23, 2
2010-02-23
Degraded Agonist Antibody
App 20090311718 - Fukushima; Naoshi ;   et al.
2009-12-17
Gene overexpressed in cancer
App 20090226918 - Aburatani; Hiroyuki ;   et al.
2009-09-10
Gene overexpressed in cancer
App 20090192108 - Aburatani; Hiroyuki ;   et al.
2009-07-30
Reshaped human antibody to human medulloblastoma cells
Grant 7,563,599 - Ohtomo , et al. July 21, 2
2009-07-21
Methods of Screening Compounds Inhibiting Signal Transduction Through Inflammatory Cytokines
App 20080160541 - Tsuchiya; Masayuki ;   et al.
2008-07-03
Gene Overexpressed in Cancer
App 20080153104 - Aburatani; Hiroyuki ;   et al.
2008-06-26
Compositions for isolating a cDNA encoding a membrane-bound protein
Grant 7,338,797 - Tsuchiya , et al. March 4, 2
2008-03-04
Methods for Enhancing Antibody Activity
App 20080009038 - Ohtomo; Toshihiko ;   et al.
2008-01-10
Cancer Diagnosis And Treatment Of Cancer Using Anti-Robo 1 Antibody
App 20070212359 - Aburatani; Hiroyuki ;   et al.
2007-09-13
Gene overexpressed in cancer
App 20070037204 - Aburatani; Hiroyuki ;   et al.
2007-02-15
Mannosyltransferase polypeptides and polynucleotides encoding them and methods for making and using them
Grant 7,067,297 - Tsuchiya , et al. June 27, 2
2006-06-27
Method of screening transporter inhibitor
App 20060084119 - Saitoh; Ryoichi ;   et al.
2006-04-20
Method for screening compounds inhibiting signal transduction through inflammatory cytokines
App 20060040316 - Tsuchiya; Masayuki ;   et al.
2006-02-23
Method for screening compounds inhibiting signal transduction through inflammatory cytokines
Grant 6,989,244 - Tsuchiya , et al. January 24, 2
2006-01-24
Reshaped human antibody to human medulloblastoma cells
App 20050249726 - Ohtomo, Toshihiko ;   et al.
2005-11-10
Gene encoding HM1.24 antigen protein and promoter thereof
Grant 6,908,750 - Ohtomo , et al. June 21, 2
2005-06-21
Compositions for isolating a cDNA encoding a membrane-bound protein
App 20050019780 - Tsuchiya, Masayuki ;   et al.
2005-01-27
Agonist antibodies
App 20040258684 - Fukushima, Naoshi ;   et al.
2004-12-23
Degraded agonist antibody
App 20040242847 - Fukushima, Naoshi ;   et al.
2004-12-02
Degraded tpo agonist antibody
App 20040091475 - Tsuchiya, Masayuki ;   et al.
2004-05-13
Agonist antibodies
App 20040058393 - Fukishima, Naoshi ;   et al.
2004-03-25
Reshaped human anti-HM 1.24 antibody
Grant 6,699,974 - Ono , et al. March 2, 2
2004-03-02
Gene encoding HM1.24 antigen protein and promoter thereof
App 20030180889 - Ohtomo, Toshihiko ;   et al.
2003-09-25
Compositions for isolating a cDNA encoding a membrane-bound protein
App 20030175794 - Tsuchiya, Masayuki ;   et al.
2003-09-18
Gene encoding HM1.24 antigen protein and promoter thereof
Grant 6,613,546 - Ohtomo , et al. September 2, 2
2003-09-02
Method of screening TGF-beta-inhibiting substances
App 20030162228 - Ono, Koichiro ;   et al.
2003-08-28
Methods for isolating a cDNA encoding a membrane-bound protein
Grant 6,610,485 - Tsuchiya , et al. August 26, 2
2003-08-26
Novel protein having signal sequence
App 20030138802 - Tsuchiya, Masayuki ;   et al.
2003-07-24
Reshaped human anti-HM 1.24 antibody
App 20030129185 - Ono, Koichiro ;   et al.
2003-07-10
Method of screening TGF-.beta.-inhibiting substances
Grant 6,551,840 - Ono , et al. April 22, 2
2003-04-22
Reshaped Human Anti-hm 1.24 Antibody
App 20030045691 - ONO, KOICHIRO ;   et al.
2003-03-06
Reshaped human antibody to human medulloblastoma cells
App 20030023045 - Ohtomo, Toshihiko ;   et al.
2003-01-30
Method of screening TGF-beta-inhibiting substances
App 20020155624 - Ono, Koichiro ;   et al.
2002-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed